Table 3 Effect of NRT treatment for less than 12 months on relapse after 12 months of smoking cessation.
Study | NRT | Placebo | Weight (%) | OR (95% CI) |
---|---|---|---|---|
Blondal 1989 | 1/30* | 1/22 | 1.6 | 0.72 (0.04 to12.2) |
Blondal 1997 | 5/20 | 2/13 | 3.8 | 1.83 (0.30 to 11.3) |
Blondal 1999 | 13/32 | 3/13 | 5.9 | 2.28 (0.52 to 9.92) |
Clavel 1997 | 23/53 | 11/43 | 16.7 | 2.23 (0.93 to 5.35) |
Daughton 1999 | 11/50 | 4/19 | 7.7 | 1.06 (0.29 to 3.84) |
Glavas 2003 | 3/13 | 1/9 | 2.1 | 2.40 (0.21 to 27.7) |
Herrera 1995 | 7/37 | 4/17 | 6.6 | 0.76 (0.19 to 3.05) |
Mikkelsen 1994 | 9/24 | 2/6 | 3.6 | 1.20 (0.18 to 7.93) |
Richmond 1997 | 8/29 | 6/14 | 7.2 | 0.51 (0.13 to 1.93) |
Stapleton 1998 | 14/33 | 7/14 | 8.2 | 0.74 (0.21 to 2.56) |
Tonnesen 1988 | 6/23 | 7/12 | 5.9 | 0.25 (0.06 to 1.11) |
Yudkin 2003 | 43/91 | 27/62 | 30.5 | 1.16 (0.61 to 2.22) |
Total | 143/435 | 75/244 | 100 | 1.11 (0.78 to 1.59) |
Random effects test of overall effect: Z = 0.74, p>0.5.
*Numbers abstinent for 12 months who relapsed before final follow up/numbers abstinent for 12 months.